Northern Trust Corp Annovis Bio, Inc. Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
A detailed history of Northern Trust Corp transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 59,514 shares of ANVS stock, worth $164,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,514
Previous 40,679
46.3%
Holding current value
$164,853
Previous $61,000
111.48%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANVS
# of Institutions
50Shares Held
1.82MCall Options Held
102KPut Options Held
98.3K-
Vanguard Group Inc Valley Forge, PA697KShares$1.93 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$507,7040.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA165KShares$455,8250.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$278,9630.0% of portfolio
-
Merit Financial Group, LLC91.3KShares$252,9450.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $22.6M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...